While clearly disappointing for the SP, would love to hear your thoughts on the rationale for an expanded NSCLC (TACTI--002) and new HNSCC (TACTI-003) trial?
with NSCLC - with additional 74 participants - is this a pathway to accelerated approval without then going through a Phase 3 (so almost a Phase 2b)? With possible results in Q1 2022, this could be a quicker way to going to market?
Interesting though about HNSCC (TACTI-003). The announcement only mentions "efti in combination with an anti-PD-1 treatment, or anti-PD-1 monotherapy". So bringing in a new partner?
- Forums
- ASX - By Stock
- IMM
- Ann: Immutep completes a A$29.6 million placement
Ann: Immutep completes a A$29.6 million placement, page-16
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
40.0¢ |
Change
-0.005(1.23%) |
Mkt cap ! $581.0M |
Open | High | Low | Value | Volume |
41.0¢ | 41.5¢ | 39.5¢ | $1.576M | 3.906M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2506 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 8079 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2506 | 0.395 |
4 | 117184 | 0.390 |
5 | 88248 | 0.385 |
8 | 91570 | 0.380 |
1 | 100000 | 0.370 |
Price($) | Vol. | No. |
---|---|---|
0.400 | 8079 | 1 |
0.405 | 30077 | 3 |
0.410 | 97079 | 4 |
0.415 | 323572 | 11 |
0.420 | 560003 | 11 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online